Do not take MOLNUPIRAVIR 200 DRL:
- if you are allergic (hypersensitive) to molnupiravir or any of the other ingredients of MOLNUPIRAVIR 200 DRL (listed in section 6).
Warnings and precautions
Tell your healthcare provider about all our medical conditions, including if you:
- are pregnant or plan to become pregnant.
- are breastfeeding or plan to breastfeed.
- have any allergies.
- have any serious illnesses.
- are taking any medicines (prescription, over-the-counter, vitamins, or herbal products).
Children and adolescents
Do not give MOLNUPIRAVIR 200 DRL to children and adolescents aged less than 18 years. The use of MOLNUPIRAVIR 200 DRL in persons aged less than 18 years has not yet been studied.
Other medicines and MOLNUPIRAVIR 200 DRL
Always tell your health care provider if you are taking any other medicine. (This includes all complementary or traditional medicines).
MOLNUPIRAVIR 200 DRL with food and drink
MOLNUPIRAVIR 200 DRL may be taken with or without food. It is advised not to drink alcohol while you are taking MOLNUPIRAVIR 200 DRL.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking MOLNUPIRAVIR 200 DRL. MOLNUPIRAVIR 200 DRL has not been studied in pregnancy and it is not known if MOLNUPIRAVIR 200 DRL will harm your baby while you are pregnant. MOLNUPIRAVIR 200 DRL is not recommended in pregnancy. If you can become pregnant, you should use effective birth control while you are taking MOLNUPIRAVIR 200 DRL and for 4 days after the last dose of MOLNUPIRAVIR 200 DRL. If you are breastfeeding or are planning to breastfeed, tell your doctor before taking this medicine. Breastfeeding is not recommended during treatment and for 4 days after the last dose of MOLNUPIRAVIR 200 DRL. This is because it is not known if MOLNUPIRAVIR 200 DRL gets into breast milk and will be passed to the baby.
Driving and using machines
It is not always possible to predict to what extent MOLNUPIRAVIR 200 DRL may interfere with the daily activities of a patient. Patients should ensure that they do not engage in the above activities until they are aware of the measure to which MOLNUPIRAVIR 200 DRL affects them. Some patients have reported dizziness during treatment with MOLNUPIRAVIR 200 DRL. If you experience this effect, do not drive or use machines until the effect wears off (see Section 4, Possible side effects).